Global Human Genetics Market 2022 - Snapshot

July 2022 | 47 pages | ID: G930DFEC08A3EN
Gen Consulting Company

Abstracts

Human genetics is the scientific study of inherited human variation. Understanding genetic factors and genetic disorders is important in learning more about promoting health and preventing disease. Some genetic changes have been associated with an increased risk of having a child with a birth defect or developmental disability or developing diseases such as cancer or heart disease. According to latest analysis by Gen Consulting Company, the global human genetics market is poised to grow by USD 52 billion during 2022-2028, progressing at a CAGR of 15.3% during the forecast period.

This industry report offers market estimates of the global market, followed by a detailed analysis of the application, test method, and region. The global market data on human genetics can be segmented by application: diagnostic & treatment, preventive medicine, others. The diagnostic & treatment segment is estimated to account for the largest share of the global human genetics market. Human genetics market is further segmented by test method: carrier testing, karyotyping, next-generation sequencing (NGS), noninvasive prenatal testing (NIPT), pharmacogenomic testing, SEPT9 biomarker testing, thrombophilia testing, others. Based on region, the human genetics market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global human genetics market is highly competitive. Key companies profiled in the report include Atrys Health S.A., Bode Cellmark Forensics Inc., Elabscience Biotechnology Inc., EUROFINS MEGALAB S.A., FULLGENOMICS S.L., GENinCode Plc, Genologica, LABORATORIO ECHEVARNE S.A., Myriad Genetics Inc., NIMGENETICS GENOMICA Y MEDICINA S.L., Sistemas Genomicos S.L., SYNLAB International GmbH.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Human Genetics Market
• Identify segments/areas to invest in over the forecast period in the Global Human Genetics Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. HUMAN GENETICS MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY APPLICATION

Diagnostic & treatment
Preventive medicine
Others

PART 5. MARKET BREAKDOWN BY TEST METHOD

Carrier testing
Karyotyping
Next-generation sequencing (NGS)
Noninvasive prenatal testing (NIPT)
Pharmacogenomic testing
SEPT9 biomarker testing
Thrombophilia testing
Others

PART 6. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 7. KEY COMPANIES

Atrys Health, S.A.
Bode Cellmark Forensics, Inc.
Elabscience Biotechnology Inc.
EUROFINS MEGALAB S.A.
FULLGENOMICS, S.L.
GENinCode Plc
Genologica
LABORATORIO ECHEVARNE S.A.
Myriad Genetics, Inc.
NIMGENETICS GENOMICA Y MEDICINA, S.L.
Sistemas Genomicos, S.L.
SYNLAB International GmbH

PART 8. METHODOLOGY